Skip to content
OpenCapital
Get started

MiMedx Group MDXG Enterprise value

Enterprise value at other companies

IAR
Integra LifeSciencesIART
$2.47B-26.7%
Artivion logo
ArtivionAORT
$1.96B+44.0%
Solventum logo
SolventumSOLV
$16.56B-19.4%
Vericel logo
VericelVCEL
$1.62B-28.0%
Enovis logo
EnovisENOV
$2.62B-25.8%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$534.65M+98.1%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

$586.8Mmarket cap+$17.6Mtotal debt−$159.8Mcash and equivalents=$444.66M

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's enterprise value?
MiMedx Group (MDXG) reported enterprise value of $444.66M in Q1 2026.
How has MiMedx Group's enterprise value changed year-over-year?
MiMedx Group's enterprise value decreased by 56.9% year-over-year, from $1.03B to $444.66M.
What is the long-term trend for MiMedx Group's enterprise value?
Over 5 years (2020 to 2025), MiMedx Group's enterprise value has grown at a -2.5% compound annual growth rate (CAGR), from $974.29M to $859.06M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.